At a glance
VIOG charges 0.1% a year, below the 0.14% average of the 8 funds most like it (the 4th cheapest of 9). It has $1.09B in assets, the 6th largest of that group; it paid 0.77% of its price in distributions over the past 12 months, quarterly. Over the past year it returned +14.5% with distributions reinvested (S&P 500: +11.5%), 7th of those 9 funds; over three years it returned +17.9% a year. At its worst it fell 27.4% in the 2022 bear market (S&P 500: 24.5%), and was back at its earlier high 25 months after the low. Its ten largest positions make up 9.8% of the fund, out of 351 in all.
The short version
Vanguard S&P Small-Cap 600 Growth ETF (VIOG) is an index fund that holds the growth-style stocks of the S&P SmallCap 600 Index, a group of smaller US companies. It had 351 holdings as of August 31, 2026. Its 0.10% expense ratio is lower than the two other funds that track the same index: SPDR's SLYG at 0.15% and iShares' IJT at 0.18%. Like most growth funds, it pays little income.
Price history
The interactive chart needs JavaScript.
VIOG +14.5% over the year to Oct 27, 2026, total return with distributions reinvested.
How it has behaved
| YTD | 1 yr | 3 yr | 5 yr | 10 yr | Since start | |
|---|---|---|---|---|---|---|
| VIOG official prospectus, to Dec 31, 2024 | — | +9.44% | — | +8.09% | +9.38% | — |
| VIOG price data to Oct 27, 2026 | +16.6% | +14.5% | +17.9% | +5.4% | — | +12.2% |
- Over the year to Oct 27, 2026, VIOG returned +14.5%, 7th of 9 among similar funds.
- Its 5-year annualized return was +5.4%.
- Its worst full calendar year was 2022 (-21.1%); its best was 2021 (+22.5%).
- The deepest fall in its price history was 29.2% (Nov 8, 2021 to Jun 16, 2022), recovered by Jul 16, 2024.
Show as a table
| Year | Price data | Prospectus (official) |
|---|---|---|
| 2026 (to date) | +16.6% | — |
| 2025 | +5.4% | — |
| 2024 | +9.2% | +9.44% |
| 2023 | +16.9% | +16.95% |
| 2022 | -21.1% | -21.22% |
| 2021 | +22.5% | +22.46% |
| 2020 | — | +19.48% |
| 2019 | — | +20.95% |
| 2018 | — | -4.18% |
| 2008 financial crisis stocks fell Oct 9, 2007 – Mar 9, 2009 | Before this security existed |
|---|---|
| 2020 COVID crash stocks fell Feb 19, 2020 – Mar 23, 2020 | Not in the price data, which starts Jun 2, 2020 |
| 2022 bear market stocks fell Jan 3, 2022 – Oct 12, 2022 | Lost 25.6% over that stretch · deepest drop along the way 27.4%, back to its old high 25 months after the low |
Dividends and income
Show as a table
| Year | Per share | Change |
|---|---|---|
| 2026 (to date) | $0.7100 | |
| 2025 | $1.2500 | +4.2% |
| 2024 | $1.2000 | -4.0% |
| 2023 | $1.2500 | +14.2% |
| 2022 | $1.0950 | +31.9% |
| 2021 | $0.8300 |
What's inside
As of Aug 31, 2026, the fund held 351 securities; the ten largest made up 9.84% of assets.
| Holding | Weight | |
|---|---|---|
| Corcept Therapeutics Inc | 1.25% | |
| Brinker International Inc | 1.13% | |
| Viasat Inc | 1.05% | |
| Protagonist Therapeutics Inc | 1.03% | |
| Ryman Hospitality Properties Inc | 1.00% | |
| FormFactor Inc | 0.90% | |
| Alkermes PLC | 0.90% | |
| Etsy Inc | 0.89% | |
| Armstrong World Industries Inc | 0.85% | |
| Glaukos Corp | 0.84% | |
| StoneX Group Inc | 0.83% | |
| TG Therapeutics Inc | 0.82% | |
| Federal Signal Corp | 0.82% | |
| Zurn Elkay Water Solutions Corp | 0.82% | |
| ESCO Technologies Inc | 0.82% |
By country
United States 99.77%By asset type
Stocks 99.77%What changed recently
- Over the three months to Aug 31, 2026, investors added a net $46.5M (creations minus redemptions, per the N-PORT report).
- Monthly total returns reported for that quarter: +9.56%, -3.28%, -1.79%.
How it works
VIOG is the exchange-traded share class of Vanguard S&P Small-Cap 600 Growth Index Fund. It tracks the S&P SmallCap 600 Growth Index. That index takes the growth companies out of the broader S&P SmallCap 600 Index, and the index provider decides which companies count as growth. "Small-cap" means a company's total stock market value is small compared with the largest US firms. Growth companies are expected to grow faster than average. They often reinvest their profits instead of paying dividends.
No manager picks stocks. Vanguard tries to own all, or nearly all, of the stocks in the index, each in about the same proportion as its weight in the index. The fund must keep at least 80% of its net assets in index stocks. As of August 31, 2026, the ten largest holdings made up just 9.84% of the fund. The biggest were Corcept Therapeutics (1.2%), Brinker International (1.1%) and Viasat (1.1%), so no single company dominates.
The prospectus lists portfolio turnover of 48%. That means a fair share of the holdings changes each year as the index changes. Cash was 0.45% of assets, and a stock index futures contract and a swap together came to about 0.01%. The shares trade on NYSE Arca at market prices, which can differ slightly from the value of the fund's holdings.
What it really costs
- VIOG charges 0.1% a year, versus an average of 0.14% for the similar funds below (4th of 9, cheapest first).
- Of that, 0.08% is the management fee; the rest covers other fund expenses.
- Using the prospectus's standard example, $10,000 invested would cost about $10 in the first year and $128 over 10 years (assuming a 5% annual return).
| Cost of $10,000 (SEC example) | 1 yr | 3 yrs | 5 yrs | 10 yrs |
|---|---|---|---|---|
| VIOG | $10 | $32 | $56 | $128 |
In a retirement portfolio
It focuses on a narrow, volatile slice of the market: small US growth companies. That fits it better as a smaller add-on than as a core holding.
VIOG could add smaller, faster-growing US companies, which large-company index funds hold little of. The price is sharper swings. Its price history starts in June 2020, so it doesn't cover the 2008 crisis or the 2020 crash. The prospectus does show a worst quarter of -28.13% in early 2020. Its worst calendar year was 2022, at -21.2%. Its deepest drop was -29.2%, from November 2021 to June 2022, and it took 25 months to recover, until July 2024. Anyone who had to sell shares or draw income during that stretch would have locked in losses. Income is thin: the trailing yield was 0.77% as of October 27, 2026, paid quarterly. Costs are low at 0.10%. In the SEC's standard example, $10,000 invested would cost about $128 over 10 years. Past results don't predict future ones, and a plan should look at the whole portfolio, not one fund.
Who it may suit — and who should look elsewhere
May suit
- Investors who want a low-cost way to own US small-cap growth stocks: 0.10%, compared with 0.15% for SLYG and 0.18% for IJT, which track the same index.
- Those adding a small position next to broad core funds to lean toward smaller growth companies such as Corcept Therapeutics and FormFactor.
- Long-term holders who can sit through drops like the -29.2% fall from 2021 to 2022, which took 25 months to recover.
Look elsewhere if
- People who need income: the trailing yield was just 0.77% as of October 27, 2026.
- Those who want every S&P 600 small-cap stock, not just growth: VIOO charges 0.07% and SPSM 0.03%.
- Investors who may need to sell in a downturn: the fund's worst quarter lost 28.13%, and three-year volatility was 19.8% as of October 27, 2026.
Close alternatives
Matched by holdings overlap from the latest N-PORT reports.
| Fund | Overlap | Cost | Net assets | 1 yr | 3 yr |
|---|---|---|---|---|---|
| VIOG this fund | — | 0.1% | $1.09B | +14.5% | +17.9% |
| SLYG SPDR S&P 600 Small Cap Growth ETF | 89% | 0.15% | $5.20B | +14.6% | +17.7% |
| IJT iShares S&P Small-Cap 600 Growth ETF | 88% | 0.18% | $8.22B | +14.4% | +17.7% |
| VIOO Vanguard S&P Small-Cap 600 ETF | 63% | 0.07% | $6.45B | +16.7% | +18.6% |
| QVMS Invesco S&P SmallCap 600 QVM Multi-factor E… | 61% | 0.15% | $248.2M | +17.1% | +18.9% |
| SPSM SPDR Portfolio S&P 600 Small Cap ETF | 61% | 0.03% | $16.92B | +21.7% | +17.4% |
| XJR iShares ESG Select Screened S&P Small-Cap E… | 60% | 0.12% | $160.7M | +15.1% | +18.5% |
| IJR iShares Core S&P Small-Cap ETF | 60% | 0.06% | $111.32B | +21.7% | +17.4% |
Questions investors ask
What does VIOG invest in?
VIOG invests in small US companies that the S&P SmallCap 600 Growth Index classifies as growth stocks. It aims to hold every stock in the index in roughly the index's proportions. As of August 31, 2026, it had 351 holdings. The largest were Corcept Therapeutics, Brinker International, Viasat, Protagonist Therapeutics and Ryman Hospitality Properties, each about 1% of the fund. The top ten together made up 9.84%, so it is spread widely across many companies.
What's the difference between VIOG and IJT?
The main difference is cost. Both track the S&P SmallCap 600 Growth Index, and their holdings overlap by about 88%. VIOG charges 0.10% a year and iShares' IJT charges 0.18%. SPDR's SLYG, a third fund tracking the same index, charges 0.15%. One-year returns as of October 27, 2026 were nearly identical: 14.5% for VIOG, 14.4% for IJT and 14.6% for SLYG. IJT is larger, with about $8.2 billion in assets as of June 30, 2026.
Does VIOG pay dividends?
Yes, but not much. VIOG pays dividends quarterly. Over the 12 months to October 27, 2026, it paid $1.08 per share, a trailing yield of 0.77%. The yield is low because growth companies tend to reinvest their profits in their business instead of paying them out. The prospectus names this as a trait of growth investing. Investors who need regular income from their portfolio would get little of it from this fund.
What is VIOG's expense ratio?
VIOG's expense ratio is 0.10% a year, according to the prospectus filed December 19, 2025. The management fee is 0.08% of that. In the SEC's standard example, $10,000 earning 5% a year would pay about $10 in costs after one year and $128 after 10 years. The average among similar funds is 0.14%. Funds that hold the whole S&P 600, not just its growth half, cost less: VIOO charges 0.07% and SPSM 0.03%.
How has VIOG performed over 10 years?
VIOG returned an average of 9.38% a year over the 10 years ending December 31, 2024, according to its prospectus. Over five years it returned 8.09% a year, and over the 2024 calendar year 9.44%. The ride was uneven. The fund rose 22.46% in 2021, then fell 21.22% in 2022. Its worst quarter, in early 2020, lost 28.13%. Its strongest quarter, at the end of 2020, gained 29.79%. Past returns don't predict future results.